{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:24:06Z","timestamp":1740108246863,"version":"3.37.3"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,5,11]],"date-time":"2019-05-11T00:00:00Z","timestamp":1557532800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,11]],"date-time":"2019-05-11T00:00:00Z","timestamp":1557532800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AR54753"],"award-info":[{"award-number":["AR54753"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s00198-019-04998-5","type":"journal-article","created":{"date-parts":[[2019,5,11]],"date-time":"2019-05-11T15:01:58Z","timestamp":1557586918000},"page":"1699-1703","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diffuse osteosclerosis as a presentation of recurrent breast cancer: role of endothelin 1"],"prefix":"10.1007","volume":"30","author":[{"given":"K. G.","family":"Zarnecki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Kristianto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Charlson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. D.","family":"Blank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6266-1029","authenticated-orcid":false,"given":"J. L.","family":"Shaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,11]]},"reference":[{"key":"4998_CR1","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1359\/jbmr.2000.15.5.844","volume":"15","author":"TJ Rosol","year":"2000","unstructured":"Rosol TJ (2000) Pathogenesis of bone metastases: role of tumor related proteins. J Bone Miner Res 15:844\u2013850","journal-title":"J Bone Miner Res"},{"issue":"1","key":"4998_CR2","doi-asserted-by":"publisher","first-page":"125","DOI":"10.4158\/EP.14.1.125","volume":"14","author":"L Eck","year":"2008","unstructured":"Eck L, Graves L III, Lukert B, Bhattacharya (2008) Sclerotic bone changes on densitometry testing in a patient with a remote history of breast cancer. Endocr Pract 14(1):125\u2013126","journal-title":"Endocr Pract"},{"issue":"1","key":"4998_CR3","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1210\/edrv.19.1.0323","volume":"19","author":"TA Guise","year":"1998","unstructured":"Guise TA, Mundy GR (1998) Cancer and bone. Endocr Rev 19(1):18\u201354. \n                              https:\/\/doi.org\/10.1210\/edrv.19.1.0323","journal-title":"Endocr Rev"},{"issue":"9","key":"4998_CR4","first-page":"2372","volume":"54","author":"A Achbarou","year":"1994","unstructured":"Achbarou A, Kaiser S, Tremblay G, Ste-Marie LG, Brodt P, Goltzman D, Rabbani SA (1994) Urokinase overproduction results in increased skeletal metastasis by prostate cancer cells in vivo. Cancer Res 54(9):2372\u20132377","journal-title":"Cancer Res"},{"key":"4998_CR5","first-page":"2577","volume":"54","author":"GN Thalmann","year":"1994","unstructured":"Thalmann GN, Anezinis PE, Chang SM, Zhau HE, Kim EE, Hopwood VL, Pathak S, con Eschenbach AC, Chung LW (1994) Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer. Cancer Res 54:2577\u20132581","journal-title":"Cancer Res"},{"key":"4998_CR6","first-page":"4096","volume":"56","author":"JR Gingrich","year":"1996","unstructured":"Gingrich JR, Barrios RJ, Morton RA, Boyce BF, DeMayo FJ, Finegold MJ, Angelopoulou R, Rosen JM, Greenberg NM (1996) Metastatic prostate cancer in a transgenic mouse. Cancer Res 56:4096\u20134102","journal-title":"Cancer Res"},{"key":"4998_CR7","first-page":"663","volume":"56","author":"JB Nelson","year":"1996","unstructured":"Nelson JB, Chan-Tach K, Hedican SP, Magnuson SR, Opgenorth TJ, , Bova GS, & Simons JW. Endothelin-1 production and decreased endothelin B receptor expression in advanced prostate Cancer (1996) Cancer Res 56, 663\u2013668","journal-title":"Cancer Res"},{"key":"4998_CR8","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1038\/nm0995-944","volume":"1","author":"JB Nelson","year":"1995","unstructured":"Nelson JB, Hedican SP, Geroge DJ, Reddi AH, Piantadosi S, Eisenberger AA, Simons JW (1995) Identification of endothelin\u20131 in the pathophysiology of metastatic adenocarcinoma of the prostate. Nat Med 1:944\u2013949","journal-title":"Nat Med"},{"key":"4998_CR9","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/S0090-4295(98)00658-X","volume":"53","author":"JB Nelson","year":"1999","unstructured":"Nelson JB, Nguyne SH, Wu-Wong JR, Opgenorth TJ, Dixon DB, Chung LW, Inoue N (1999) New bone formation in an osteoblastic tumor model is increased by endothelin-1 overexpression and decreased by endothelin a receptor blockade. Urology 53:1063\u20131069","journal-title":"Urology"},{"issue":"2","key":"4998_CR10","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1124\/pr.115.011833","volume":"68","author":"AP Davenport","year":"2016","unstructured":"Davenport AP, Hyndman KA, Dhaun N, Southan C, Kohan DE, Pollock JS, Pollock DM, Webb DJ, Maguire JJ (2016 Apr) Endothelin. Pharmacol Rev 68(2):357\u2013418. \n                              https:\/\/doi.org\/10.1124\/pr.115.011833","journal-title":"Pharmacol Rev"},{"issue":"9","key":"4998_CR11","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/nrc3546","volume":"13","author":"L Rosan\u00f2","year":"2013","unstructured":"Rosan\u00f2 L, Spinella F, Bagnato A (2013) Endothelin 1 in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer 13(9):637\u2013651. \n                              https:\/\/doi.org\/10.1038\/nrc3546","journal-title":"Nat Rev Cancer"},{"issue":"19","key":"4998_CR12","doi-asserted-by":"publisher","first-page":"10954","DOI":"10.1073\/pnas.1830978100","volume":"100","author":"TA Guise","year":"2003","unstructured":"Guise TA (2003) A causual role for endothelin-1 in the pathogenesis of osteoblastic bone metastases. PNAS 100(19):10954\u201310959","journal-title":"PNAS"},{"key":"4998_CR13","first-page":"7","volume":"2013","author":"D Tamkus","year":"2013","unstructured":"Tamkus D, Sikorskii A, Gallo K, Wiese D, Leece C, Madhukar B, Chivu S, Chitneni S, Dimitrov N (2013) Endothelin-1 enriched tumor phenotype predicts breast cancer recurrence. ISRN Oncol 2013:7","journal-title":"ISRN Oncol"},{"key":"4998_CR14","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1146\/annurev.pharmtox.41.1.851","volume":"41","author":"RM Kedzierski","year":"2001","unstructured":"Kedzierski RM, Yanagisawa M (2001) Endothelin system: the double-edged sword in health and disease. Annu Rev Pharmacol Toxicol 41:851\u2013876","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"4998_CR15","doi-asserted-by":"publisher","first-page":"5999","DOI":"10.1073\/pnas.90.13.5999","volume":"90","author":"AM Malek","year":"1993","unstructured":"Malek AM, Greene AL, Izumo S (1993) Regulation of endothelin 1 gene by fluid shear stress is transcriptionally mediated and independent of protein kinase C and cAMP. Proc Natl Acad Sci U S A 90:5999\u20136003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4998_CR16","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/0092-8674(94)90425-1","volume":"78","author":"D Xu","year":"1994","unstructured":"Xu D, Emoto N, Giaid A, Slaughter C, Kaw S, deWit D, Yanagisawa M (1994) ECE-1: a membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1. Cell 78:473\u2013485","journal-title":"Cell"},{"issue":"3","key":"4998_CR17","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0167-0115(96)00122-X","volume":"67","author":"K Wolff","year":"1996","unstructured":"Wolff K, Nisell H, Carlstr\u00f6m K, Kublickiene K, Hems\u00e9n A, Lunell N-O, Lindblom B (1996) Endothelin-1 and big endothelin-1 levels in normal term pregnancy and in preeclampsia. Regul Pept 67(3):211\u2013216. \n                              https:\/\/doi.org\/10.1016\/s0167-0115(96)00122-x","journal-title":"Regul Pept"},{"issue":"8","key":"4998_CR18","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1111\/j.1651-2227.1997.tb08599.x","volume":"86","author":"S Ken-Dror","year":"2008","unstructured":"Ken-Dror S, Weintraub Z, Yechiely H, Kahana L (2008) Atrial natriuretic peptide and endothelin concentrations in human milk during postpartum lactation. Acta Paediatr 86(8):793\u2013795. \n                              https:\/\/doi.org\/10.1111\/j.1651-2227.1997.tb08599.x","journal-title":"Acta Paediatr"},{"issue":"2","key":"4998_CR19","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1210\/me.2006-0346","volume":"21","author":"G Clines","year":"2007","unstructured":"Clines G, Mohammad KS, Bao Y, Stephens O, Suva L, Shaughnessy JD, Fox JW, Chirgwin J, Guise T (2007) Dickkopf homolog 1 mediates Endothelin-1-stimulated new bone formation. Mol Endocrinol 21(2):486\u2013498","journal-title":"Mol Endocrinol"},{"issue":"Suppl 1","key":"4998_CR20","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3109\/03008207.2014.923866","volume":"55","author":"MG Johnson","year":"2014","unstructured":"Johnson MG, Kristianto J, Yuan B, Konicke K, Blank R (2014) Big endothelin changes the cellular miRNA environment in TMOb osteoblasts and increases mineralization. Connect Tissue Res 55(Suppl 1):113\u2013116","journal-title":"Connect Tissue Res"},{"issue":"7","key":"4998_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0133803","volume":"10","author":"P Qi","year":"2015","unstructured":"Qi P, Chen M, Zhang LX, Song RX, He ZH, Wang ZP (2015) A meta-analysis and indirect comparison of endothelin a receptor antagonist for castration-resistant prostate cancer. PLoS One 10(7):e0133803","journal-title":"PLoS One"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-019-04998-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-019-04998-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-019-04998-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T07:46:22Z","timestamp":1589442382000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-019-04998-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,11]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["4998"],"URL":"https:\/\/doi.org\/10.1007\/s00198-019-04998-5","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"type":"print","value":"0937-941X"},{"type":"electronic","value":"1433-2965"}],"subject":[],"published":{"date-parts":[[2019,5,11]]},"assertion":[{"value":"29 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None directly related to this work, Jasmin Kristianto Employee: Unity Biotechnology John Charlson Advisory Board:Immune Design Clinical trial funding: Lilly Oncology Robert D. Blank Consultant: Amgen, Novo-Nordisk, Radius Health, Ultragenyx Authorship Royalties: UpToDate, McGraw-Hill Ownership Interest: JangoBio, Abbott Laboratories, Abbvie Joseph L. Shaker Consultant Shire, Alexion, Ultragenyx Authorship Royalties: McGraw-Hill.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}